Inventor · disambiguated record
Michelle Lafond
Also filed as: LaFond Michelle
2 granted patents·8 pending applications·1 citations·filing 2016–2023
38Inventor score
Files withREGENERON PHARMA10
Top patents by PatentIndex Score
10 records- 0182US2023348532A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0282US2023331776A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0382US2023332084A1Bioreactor for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0482US2023287043A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0582US2023332201A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0682US2024010737A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0771US12291563B2Metabolically optimized cell cultureREGENERON PHARMA·Filed 2022·Granted May 6, 2025·0 cites·15 claims
- 0868US11390663B2Metabolically optimized cell cultureREGENERON PHARMA·Filed 2016·Granted Jul 19, 2022·1 cites·15 claims
- 0952US2023129265A1Systems and methods for generating laboratory water and distributing laboratory water at different temperaturesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1032US2016244726A1Metabolically optimized cell cultureREGENERON PHARMA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michelle Lafond files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →